Home › NDC Lookup › Ingredients › Lidocaine Hydrochloride And Benzalkonium... › 68229-0408-01
Alocane Max Lidocaine Hydrochloride and Benzalkonium Chloride 4 g/100mL; .13 g/100mL Spray, 104 mL — NDC 68229-0408-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Alocane Max Lidocaine Hydrochloride and Benzalkonium Chloride 4 g/100mL; .13 g/100mL Spray, 104 mL — NDC 68229-408-01 (Billing 68229-0408-01)

by Quest Products LLC · 104 mL in 1 BOTTLE, SPRAY

This is a package of 104 mL of Alocane Max Lidocaine Hydrochloride and Benzalkonium Chloride 4 g/100mL; .13 g/100mL Spray from Quest Products LLC, marketed since Nov 2023 and currently FDA-listed. It is the main listing for this product, which comes in 3 package sizes.

NDC 68229-0408-01
🏷️ FDA NDC (as labeled) 68229-408-01 billing pads the product segment with a zero
This package
Contains104 mL Pack sizes3 compare ↓
Main listing for product 68229-408 · Also comes in: 118 ml 68229-408-02 124 ml 68229-408-03
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 68229-408-01
Product NDC 68229-408
11-digit billing NDC 68229040801
NCPDP billing unit ML — per mL (volume)
RxCUI 2047877, 2477939
UNII V13007Z41A, F5UM2KM3W7
UPC 0846241032581
Application # M017
SPL Set ID 0a35221a-2fcb-2735-e063-6294a90a88ca
Established class (EPC) Amide Local Anesthetic; Antiarrhythmic
Physiologic effect Local Anesthesia
Chemical class Amides
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-11-15
Route TOPICAL
Dosage form SPRAY
Substance LIDOCAINE HYDROCHLORIDE; BENZALKONIUM CHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 085280
GCN 54724
HICL code 010610
Ingredient (HICL) Lidocaine Hcl/Benzalkonium Chl
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5H
Therapeutic class — specific (HIC3) Topical Local Anesthetics
AHFS code 72:00.00.00
AHFS class Local Anesthetics
FDB label name ALOCANE-ANTISEPTIC 4-0.13% SPR
FDB brand name Alocane With Antiseptic
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 085280
  • GCN: 54724
  • HICL (First Databank): 010610
  • AHFS class code: 72:00.00.00
  • RxCUI (RxNorm): 2047877
Why two NDCs? The FDA registers this code as 68229-408-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 68229-0408-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Quaternary ammonium compounds class.

Drug family (ATC) Quaternary ammonium compounds, Medicated dressings with antiinfectives, Antiseptics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name ALOCANE-ANTISEPTIC 4-0.13% SPR Ingredient Lidocaine Hcl/Benzalkonium Chl
🧪 What is this product?

Alocane Max is a topical spray containing lidocaine hydrochloride and benzalkonium chloride. Lidocaine is a local anesthetic typically used to numb skin and provide temporary pain relief, while benzalkonium chloride is an antimicrobial agent commonly included to help reduce bacteria. This over-the-counter monograph product is applied directly to the skin surface by spray application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 118 ml 124 ml
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
68229-0408-01 You're viewing this Main listing 104 mL in 1 BOTTLE, SPRAY 2023-11-15 — Active
68229-0408-02 68229-408-02 118 mL in 1 BOTTLE, SPRAY 2023-11-15 — Active
68229-0408-03 68229-408-03 124 mL in 1 BOTTLE, SPRAY 2023-11-15 — Active

You're viewing the smallest of 3 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This package contains 104 mL — 104 ml in 1 bottle, spray.
How does this package differ from NDC 68229-0408-02?
Both are Alocane Max Lidocaine Hydrochloride and Benzalkonium Chloride 4 g/100mL; .13 g/100mL Spray — the drug itself is identical. This page's package is the 104 mL one, while NDC 68229-0408-02 is the 118 ml package.
What NDC number is used to bill for this package of Alocane Max Lidocaine Hydrochloride and Benzalkonium Chloride 4 g/100mL; .13 g/100mL Spray?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Walgreen Maximum strength pain relieving cleansing .13 g/100mL; 4 g/100mL 00363-7020-05 WALGREENS 148 ml — — FDA listed —
RITE AID Maximum strength pain relieving .13 g/100mL; 4 g/100mL 11822-7220-05 RITE 148 ml — — FDA listed —
Signature Select Pain Relieving .13 g/100mL; 4 g/100mL 21130-0931-01 Safeway/Albartsons 148 ml — — FDA listed —
Meijer Maximum strength pain relieving cleansing .13 g/100mL; 4 g/100mL 41250-0287-05 MEIJER 148 ml — — FDA listed —
American Red Cross First Aid 1.3 mg/mL; 40 mg/mL 51628-0368-00 MY 88.72 ml — — FDA listed —
American Red Cross First Aid 4 g/100g; .13 g/100g 51628-4529-01 MY 141 g — — FDA listed —
Medline .13 g/100g; 4 g/100g 53329-0918-04 Medline 113 g — — FDA listed —
Medline 4 g/100g; .13 g/100g 53329-0919-04 Medline 113 g — — FDA listed —
Bactine Max .13 g/100mL; 4 g/100mL 65197-0811-14 WellSpring 118 ml — — FDA listed —
Alocane Plus 4 g/100mL; .13 g/100mL 68229-0404-01 Quest 104 ml — — FDA listed —
Alocane Max 4 g/100mL; .13 g/100mLthis 68229-0408-01 Quest 104 ml — — FDA listed —
Pain Relieving cleansing spary .0013 g/mL; .04 g/mL 69396-0177-05 Trifecta 148 ml — — FDA listed —
HealthWise Lidocaine Cleansing .13 g/100mL; 4 g/100mL 71101-0101-01 Veridian 148 ml — — FDA listed —
DG Health Maximum Strength Pain Relieving Cleansing 1.3 mg/mL; 40 mg/mL 75712-0200-01 Dollar 148 ml — — FDA listed —
American Red Cross First Aid 4 g/100g; .13 g/100g 75742-0072-01 Zhejiang 141 g — — FDA listed —
Thera Plus Pain Relief Cleansing 1.3 mg/mL; 40 mg/mL 80684-0150-00 Fourstar 148 ml — — FDA listed —
Up and Up Max Pain Relieving Cleansing .13 g/100mL; 4 g/100mL 82442-0018-21 TARGET 150 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Nov 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 9E8X80D2L0
    A synthetic form of vitamin E used as an antioxidant and preservative in medications. It helps prevent the active ingredients from degrading when exposed to oxygen or light.
  • UNII ZY81Z83H0X
    Aloe vera leaf is a plant extract derived from the aloe plant. It is used in medicines as a natural moisturizer and skin-soothing agent in topical formulations.
  • UNII 00YIU5438U
    Caprylyl glycol is a clear liquid derived from coconut oil. In medicines, it acts as a humectant to retain moisture, a preservative booster to prevent microbial growth, and a solvent to help dissolve or mix other ingredients.
  • UNII I670DAL4SZ
    A preservative that fights bacteria and fungi. It keeps medicines and topical products stable and safe from microbial contamination during storage and use.
  • UNII SA6A6V432S
    Dimethyl isosorbide is a clear liquid solvent derived from natural sugar sources. It helps dissolve active ingredients and improve their absorption in liquid medicines and topical products.
  • UNII M825OX60H9
    Hydroxyethyl cellulose is a plant-derived thickener made by chemically treating cellulose. In medicines, it acts as a binder to hold ingredients together, a thickener to control texture, and sometimes a film-former for coatings.
  • UNII HIE492ZZ3T
    Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
  • UNII 5965N8W85T
    Propanediol is a clear liquid organic compound derived from vegetable sources or synthesized chemically. It acts as a humectant to retain moisture, a solvent to dissolve active ingredients, and a preservative booster in liquid medications and supplements.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

9 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesAloe Barbadensis (Aloe) Leaf Juice, Caprylyl Glycol, Chlorphenesin, Dimethyl Isosorbide, Hydroxyethyl Cellulose, Phenoxyethanol, Propanediol, Tocopheryl Acetate (Vitamin E), Water.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerQuest Products LLC
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code68229
First marketedNov 2023
Product typeHuman Otc Drug
Portfolio5 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 29 words ▾

Uses: First aid to help prevent bacterial icontamination or skin infection, and for temporary relief of pain and itching associated with minor: Burns Cuts Sunburn Scrapes Minor Skin Irritation

⏱️ Dosage and Administration 56 words ▾

Directions Adults and children 2 years of age and older: Clean the affected area. Spray a small amount on the affected area 3 to 4 times daily. May be covered with a sterile bandage (let dry first). To apply to the face, spray on palm and apply. Children under 2 years of age: ask a doctor.

⚠️ Warnings 103 words ▾

Warnings For external use only. Ask a doctor before use if you have: Deep or puncture wounds Animal Bites Serious burns Do not use: In or near the eyes In large quantities or over large areas of the body On raw surfaces or blistered areas Stop use and ask doctor: if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days. If pregnant or breast-feeding , ask a health care professional before use.

Keep out of reach of children. If swallowed, get medical help or call a Poison Control Center right away.

📦 Storage and Handling 6 words ▾

Other Information Store at 15°-30°C (59°-86°F)

🧪 Active Ingredient 14 words ▾

Active Ingredient Purpose Benzalkonium Chloride 0.13% Lidocaine HCL 4% First Aid Antiseptic Topical Analgesic

🧪 Inactive Ingredients 21 words ▾

Inactive Ingredients Aloe Barbadensis (Aloe) Leaf Juice, Caprylyl Glycol, Chlorphenesin, Dimethyl Isosorbide, Hydroxyethyl Cellulose, Phenoxyethanol, Propanediol, Tocopheryl Acetate (Vitamin E), Water.

🎯 Purpose 14 words ▾

Active Ingredient Purpose Benzalkonium Chloride 0.13% Lidocaine HCL 4% First Aid Antiseptic Topical Analgesic

📄 Do Not Use 24 words ▾

Do not use: In or near the eyes In large quantities or over large areas of the body On raw surfaces or blistered areas

📄 Ask a Doctor Before Use If 16 words ▾

Ask a doctor before use if you have: Deep or puncture wounds Animal Bites Serious burns

📄 Stop Use and Ask a Doctor If 27 words ▾

Stop use and ask doctor: if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days.

🤰 If Pregnant or Breast-Feeding 12 words ▾

If pregnant or breast-feeding , ask a health care professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or call a Poison Control Center right away.

📄 Package Label / Principal Display Panel 9 words ▾

PRINCIPAL DISPLAY PANEL - 3.5 fl oz spray PDP

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Lidocaine Hydrochloride and Benzalkonium Chloride — the ingredient across all brands.

Top reported reactions

Cerebrovascular Accident1
Death1

Reporter sex

1 reports
Male · 100%
Reports over time (by year) — tap or hover for the count & year
2025 2026 1 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Quest Products LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 118 ml (68229-0408-02), 124 ml (68229-0408-03). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Quest Products LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 68229-0407-02 · Quest 68229-0409-02 · Quest →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.